业务
货币单位:人民币
2025/FY
名称营收比例
Oncology drugs22.97亿36.42%
Central nervous system drugs20.28亿32.15%
Cardiovascular system drugs11.52亿18.27%
其他4.82亿7.64%
Alimentary tract and metabolism drugs3.49亿5.53%
地区
货币单位:人民币
2025/FY
名称营收比例
中国内地51.36亿81.41%
欧盟5.39亿8.54%
Asia (other than the Chinese mainland)4.99亿7.91%
其他国家1.34亿2.13%